Skip to content Skip to footer

Research Portal of the TU Dresden

Breast Cancer Research and Treatment

ISSNs: 0167-6806

Additional searchable ISSN (electronic): 1573-7217

Springer Verlag, New York

Scopus rating (2022): CiteScore 7.5 SJR 1.442 SNIP 1.312

Journal

Titles	Breast Cancer Research and Treatment Breast cancer research and treatment
Additional searchable titles	Breast cancer research and treatment, Breast cancer research and treatment., Breast Cancer Res Treat
ISSNs	0167-6806
Additional searchable ISSN (electronic)	1573-7217
Publisher	Springer Verlag, New York
ZDB-ID	604563-7
ZDB-ID	2004077-5

Keywords

ASJC Scopus subject areas

Oncology
Cancer Research

Library keywords

610 Medicine and health

Related content

Research output

Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T: results from a German non-interventional study (NIS) HELENA (NCT01777958)

Thill, M., Wimberger, P., Grafe, A., Klare, P., Luedtke-Heckenkamp, K., Reichert, D., Zaiss, M., & 3 othersZiegler-Löhr, K., Eckl, T. & Schneeweiss, A., Nov 2022, In: Breast cancer research and treatment. 196, 2, p. 311-321 11 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

High serum levels of periostin are associated with a poor survival in breast cancer

Rachner, T. D., Göbel, A., Hoffmann, O., Erdmann, K., Kasimir-Bauer, S., Kimmig, R., Hofbauer, L. C., & 1 othersBittner, A. K., 1 Apr 2020, In: Breast cancer research and treatment. 180, 2, p. 515-524 10 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer

the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC), 15 May 2019, In: Breast cancer research and treatment. 175, 1, p. 217-228 12 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients.

Göbel, A., Kuhlmann, J. D., Link, T., Wimberger, P., Browne, A. J., Rauner, M., Hofbauer, L. C., & 1 othersRachner, T. D., 2017, In: Breast Cancer Research and Treatment. 164, 3, p. 737-743 7 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome.

Concolino, P., Rizza, R., Hackmann, K., Paris, I., Minucci, A., De Paolis, E., Scambia, G., & 3 othersZuppi, C., Schröck, E. & Capoluongo, E., 2017, In: Breast Cancer Research and Treatment. p. 497-503 7 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (9)